Hugo Cheinquer
Overview
Explore the profile of Hugo Cheinquer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
960
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Razavi H, Waked I, Qureshi H, Kondili L, Duberg A, Aleman S, et al.
J Hepatol
. 2025 Feb;
PMID: 39914746
Background And Aims: The year 2023 marked the 10-year anniversary of the launch of direct-acting antivirals (DAAs) for the treatment of the hepatitis C virus (HCV). HCV treatment trends by...
2.
Benetti F, de Araujo A, de Maman Junior I, Coelho Borges Cheinquer C, Herz Wolff F, Cheinquer H
Arch Endocrinol Metab
. 2024 May;
68:e220480.
PMID: 38709148
Objective: The aim of this study was to evaluate the glycated hemoglobin (HbA1c) levels before and after sustained virologic response (SVR) and investigate the baseline characteristics associated with improved glycemic...
3.
Cooke G, Flower B, Cunningham E, Marshall A, Lazarus J, Palayew A, et al.
Lancet Gastroenterol Hepatol
. 2024 Feb;
9(4):346-365.
PMID: 38367629
The top 20 highest burdened countries (in disability-adjusted life years) account for more than 75% of the global burden of viral hepatitis. An effective response in these 20 countries is...
4.
Toyoda H, Kanneganti M, Melendez-Torres J, Parikh N, Jalal P, Pinero F, et al.
Clin Gastroenterol Hepatol
. 2023 Jul;
22(1):72-80.e4.
PMID: 37442316
Background & Aims: Widespread use of direct-acting antivirals for hepatitis C virus infection has been paralleled with increased numbers of patients with hepatocellular carcinoma (HCC) after achieving sustained virologic response...
5.
Chagas A, Leal C, Mello V, Barros F, Bittencourt P, Mattos A, et al.
Arq Gastroenterol
. 2023 May;
60(1):106-131.
PMID: 37194769
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2020 the updated recommendations for the diagnosis and treatment...
6.
Pinero F, Anders M, Bermudez C, Demirdjian E, Varon A, Palazzo A, et al.
Ann Hepatol
. 2023 Apr;
28(4):101110.
PMID: 37100385
Introduction And Objectives: With the advent of new therapeutic options for patients with hepatocellular carcinoma (HCC) for intermediate or advanced stages of the Barcelona Clinic Liver Cancer (BCLC), regional real-world...
7.
Razavi H, Buti M, Terrault N, Zeuzem S, Yurdaydin C, Tanaka J, et al.
J Hepatol
. 2023 Apr;
79(2):576-580.
PMID: 37030400
Hepatitis D virus (HDV) infection occurs as a coinfection with hepatitis B and increases the risk of hepatocellular carcinoma, decompensated cirrhosis, and mortality compared to hepatitis B virus (HBV) monoinfection....
8.
Mendizabal M, Thompson M, Gonzalez-Ballerga E, Anders M, Castro-Narro G, Pessoa M, et al.
J Viral Hepat
. 2022 Oct;
30(1):56-63.
PMID: 36197907
To achieve WHO's goal of eliminating hepatitis C virus (HCV), innovative strategies must be designed to diagnose and treat more patients. Therefore, we aimed to describe an implementation strategy to...
9.
Ferraz M, Piccoli L, Rezende R, Borba L, Pissaia Junior A, Cheinquer H, et al.
Braz J Infect Dis
. 2022 Jul;
26(4):102388.
PMID: 35905930
Background And Aims: Treatment of hepatitis C with direct antiviral agents (DAA) is associated with almost 95% of sustained virological response. However, some patients need retreatment. In Brazil, it should...
10.
Fabrizi F, Alonso C, Palazzo A, Anders M, Reggiardo M, Cheinquer H, et al.
Ann Hepatol
. 2021 Mar;
25:100337.
PMID: 33684523
Introductions And Objectives: The introduction of direct-acting antiviral (DAA) agents promises to change dramatically the management of hepatitis C in kidney transplant recipients, a patient group where the treatment of...